{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T17:37:32Z","timestamp":1788802652665,"version":"build-2803163510"},"reference-count":176,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T00:00:00Z","timestamp":1675123200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T00:00:00Z","timestamp":1675123200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biotechnol"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s12033-023-00679-1","type":"journal-article","created":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T16:08:05Z","timestamp":1675181285000},"page":"1387-1402","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Application of Cell Penetrating Peptides as a Promising Drug Carrier to Combat Viral Infections"],"prefix":"10.1007","volume":"65","author":[{"given":"Niloofar","family":"Khairkhah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Namvar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7363-7406","authenticated-orcid":false,"given":"Azam","family":"Bolhassani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,31]]},"reference":[{"key":"679_CR1","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1517\/17425247.2016.1125879","volume":"13","author":"K Kurrikoff","year":"2016","unstructured":"Kurrikoff, K., Gestin, M., & Langel, \u00dc. (2016). Recent in vivo advances in cell-penetrating peptide-assisted drug delivery. Expert Opinion on Drug Delivery, 13, 373\u2013387.","journal-title":"Expert Opinion on Drug Delivery"},{"key":"679_CR2","doi-asserted-by":"publisher","first-page":"600","DOI":"10.3390\/ph3030600","volume":"3","author":"V Kersemans","year":"2010","unstructured":"Kersemans, V., & Cornelissen, B. (2010). Targeting the tumour: Cell penetrating peptides for molecular imaging and radiotherapy. Pharmaceuticals, 3, 600\u2013620.","journal-title":"Pharmaceuticals"},{"key":"679_CR3","doi-asserted-by":"publisher","first-page":"528","DOI":"10.3892\/br.2016.639","volume":"4","author":"Z Guo","year":"2016","unstructured":"Guo, Z., Peng, H., Kang, J., & Sun, D. (2016). Cell-penetrating peptides: Possible transduction mechanisms and therapeutic applications. Biomedical Reports, 4, 528\u2013534.","journal-title":"Biomedical Reports"},{"key":"679_CR4","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jconrel.2013.11.020","volume":"174","author":"F Wang","year":"2014","unstructured":"Wang, F., Wang, Y., Zhang, X., Zhang, W., Guo, S., & Jin, F. (2014). Recent progress of cell-penetrating peptides as new carriers for intracellular cargo delivery. Journal of Controlled Release, 174, 126\u2013136.","journal-title":"Journal of Controlled Release"},{"key":"679_CR5","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1016\/j.febslet.2009.11.046","volume":"584","author":"N Schmidt","year":"2010","unstructured":"Schmidt, N., Mishra, A., Lai, G. H., & Wong, G. C. (2010). Arginine-rich cell-penetrating peptides. FEBS Letters, 584, 1806\u20131813.","journal-title":"FEBS Letters"},{"key":"679_CR6","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/0092-8674(88)90262-0","volume":"55","author":"M Green","year":"1988","unstructured":"Green, M., & Loewenstein, P. M. (1988). Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell, 55, 1179\u20131188.","journal-title":"Cell"},{"key":"679_CR7","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/0092-8674(88)90263-2","volume":"55","author":"AD Frankel","year":"1988","unstructured":"Frankel, A. D., & Pabo, C. O. (1988). Cellular uptake of the tat protein from human immunodeficiency virus. Cell, 55, 1189\u20131193.","journal-title":"Cell"},{"key":"679_CR8","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.tibs.2015.10.004","volume":"40","author":"WB Kauffman","year":"2015","unstructured":"Kauffman, W. B., Fuselier, T., He, J., & Wimley, W. C. (2015). Mechanism matters: A taxonomy of cell penetrating peptides. Trends in Biochemical Sciences., 40, 749\u2013764.","journal-title":"Trends in Biochemical Sciences."},{"key":"679_CR9","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.tips.2017.01.003","volume":"38","author":"G Guidotti","year":"2017","unstructured":"Guidotti, G., Brambilla, L., & Rossi, D. (2017). Cell-penetrating peptides: From basic research to clinics. Trends in Pharmacological Sciences., 38, 406\u2013424.","journal-title":"Trends in Pharmacological Sciences."},{"key":"679_CR10","doi-asserted-by":"publisher","first-page":"D1098","DOI":"10.1093\/nar\/gkv1266","volume":"44","author":"P Agrawal","year":"2016","unstructured":"Agrawal, P., Bhalla, S., Usmani, S. S., Singh, S., Chaudhary, K., Raghava, G. P., & Gautam, A. (2016). CPPsite 2.0: A repository of experimentally validated cell-penetrating peptides. Nucleic Acids Research, 44, D1098\u2013D1103.","journal-title":"Nucleic Acids Research"},{"key":"679_CR11","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.3390\/molecules26061591","volume":"26","author":"F Gayraud","year":"2021","unstructured":"Gayraud, F., Klu\u00dfmann, M., & Neundorf, I. (2021). Recent advances and trends in chemical CPP-drug conjugation techniques. Molecules, 26, 1591.","journal-title":"Molecules"},{"key":"679_CR12","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.4103\/jfmpc.jfmpc_2071_20","volume":"10","author":"P Bhadoria","year":"2021","unstructured":"Bhadoria, P., Gupta, G., & Agarwal, A. (2021). Viral pandemics in the past two decades: An overview. Journal of Family Medicine and Primary Care, 10, 2745.","journal-title":"Journal of Family Medicine and Primary Care"},{"key":"679_CR13","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.ijbiomac.2021.01.076","volume":"172","author":"DR Tompa","year":"2021","unstructured":"Tompa, D. R., Immanuel, A., Srikanth, S., & Kadhirvel, S. (2021). Trends and strategies to combat viral infections: A review on FDA approved antiviral drugs. International Journal of Biological Macromolecules, 172, 524\u2013541.","journal-title":"International Journal of Biological Macromolecules"},{"key":"679_CR14","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/nature02759","volume":"430","author":"DM Morens","year":"2004","unstructured":"Morens, D. M., Folkers, G. K., & Fauci, A. S. (2004). The challenge of emerging and re-emerging infectious diseases. Nature, 430, 242\u2013249.","journal-title":"Nature"},{"key":"679_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/2212711906999200228100507","volume":"6","author":"AP Peter","year":"2020","unstructured":"Peter, A. P., Wayne, C. K., Show, P. L., & Ling, T. C. (2020). Potential pathway that could treat Coronaviruses (COVID-19). Curr Biochem Eng, 6, 3\u20134.","journal-title":"Curr Biochem Eng"},{"key":"679_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.aquaculture.2021.736737","volume":"540","author":"PT Lanh","year":"2021","unstructured":"Lanh, P. T., Nguyen, H. M., Duong, B. T. T., Hoa, N. T., Thom, L. T., Tam, L. T., Thu, H. T., Nha, V. V., Hong, D. D., Mouradov, A., Koyande, A. K., Show, P. L., & Quyen, D. V. (2021). Generation of microalga Chlamydomonas reinhardtii expressing VP28 protein as oral vaccine candidate for shrimps against white spot syndrome virus (WSSV) infection. Aquaculture, 540, 736737.","journal-title":"Aquaculture"},{"key":"679_CR17","doi-asserted-by":"crossref","unstructured":"Khairkhah, N., Bolhassani, A., & Najafipour R. (2022). Current and future direction in treatment of HPV-related cervical disease. Journal of Molecular Medicine, 1-17","DOI":"10.1007\/s00109-022-02199-y"},{"key":"679_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4167\/jbv.2018.48.1.1","volume":"48","author":"KA Hwang","year":"2018","unstructured":"Hwang, K. A., Ahn, J. H., & Nam, J. H. (2018). Diagnosis of viral infection using real-time polymerase chain reaction. Journal of Bacteriology and Virology, 48, 1\u201313.","journal-title":"Journal of Bacteriology and Virology"},{"key":"679_CR19","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.bios.2017.02.038","volume":"94","author":"SS Low","year":"2017","unstructured":"Low, S. S., Loh, H. S., Boey, J. S., Khiew, P. S., Chiu, W. S., & Tan, M. T. T. (2017). Sensitivity enhancement of graphene\/zinc oxide nanocomposite-based electrochemical impedance genosensor for single stranded RNA detection. Biosensors and Bioelectronics, 94, 365\u2013373.","journal-title":"Biosensors and Bioelectronics"},{"key":"679_CR20","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.tips.2013.11.006","volume":"35","author":"Z Lou","year":"2014","unstructured":"Lou, Z., Sun, Y., & Rao, Z. (2014). Current progress in antiviral strategies. Trends in Pharmacological Sciences, 35, 86\u2013102.","journal-title":"Trends in Pharmacological Sciences"},{"key":"679_CR21","doi-asserted-by":"publisher","first-page":"448","DOI":"10.3390\/ph3030448","volume":"3","author":"M Delcroix","year":"2010","unstructured":"Delcroix, M., & Riley, L. W. (2010). Cell-penetrating peptides for antiviral drug development. Pharmaceuticals, 3, 448\u2013470.","journal-title":"Pharmaceuticals"},{"key":"679_CR22","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1096\/fj.05-5523com","volume":"20","author":"G T\u00fcnnemann","year":"2006","unstructured":"T\u00fcnnemann, G., Martin, R. M., Haupt, S., Patsch, C., Edenhofer, F., & Cardoso, M. C. (2006). Cargo-dependent mode of uptake and bioavailability of TAT-containing proteins and peptides in living cells. The FASEB Journal, 20, 1775\u20131784.","journal-title":"The FASEB Journal"},{"key":"679_CR23","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/bs.apcsb.2014.12.001","volume":"98","author":"AP Jallouk","year":"2015","unstructured":"Jallouk, A. P., Palekar, R. U., Pan, H., Schlesinger, P. H., & Wickline, S. A. (2015). Modifications of natural peptides for nanoparticle and drug design. Advances in Protein Chemistry and Structural Biology, 98, 57\u201391.","journal-title":"Advances in Protein Chemistry and Structural Biology"},{"key":"679_CR24","doi-asserted-by":"publisher","first-page":"9208","DOI":"10.1021\/bi0201466","volume":"41","author":"E Hariton-Gazal","year":"2002","unstructured":"Hariton-Gazal, E., Feder, R., Mor, A., Graessmann, A., Brack-Werner, R., Jans, D., Gilon, C., & Loyter, A. (2002). Targeting of nonkaryophilic cell-permeable peptides into the nuclei of intact cells by covalently attached nuclear localization signals. Biochemistry, 41, 9208\u20139214.","journal-title":"Biochemistry"},{"key":"679_CR25","doi-asserted-by":"publisher","first-page":"961","DOI":"10.3390\/ph3040961","volume":"3","author":"S Trabulo","year":"2010","unstructured":"Trabulo, S., Cardoso, A. L., Mano, M., & De Lima, M. C. P. (2010). Cell-penetrating peptides-mechanisms of cellular uptake and generation of delivery systems. Pharmaceuticals, 3, 961\u2013993.","journal-title":"Pharmaceuticals"},{"key":"679_CR26","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/bip.20421","volume":"84","author":"S Futaki","year":"2006","unstructured":"Futaki, S. (2006). Oligoarginine vectors for intracellular delivery: Design and cellular-uptake mechanisms. Peptide Science: Original Research on Biomolecules, 84, 241\u2013249.","journal-title":"Peptide Science: Original Research on Biomolecules"},{"key":"679_CR27","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1034\/j.1399-3011.2000.00723.x","volume":"56","author":"DJ Mitchell","year":"2000","unstructured":"Mitchell, D. J., Steinman, L., Kim, D., Fathman, C., & Rothbard, J. (2000). Polyarginine enters cells more efficiently than other polycationic homopolymers. The Journal of Peptide Research, 56, 318\u2013325.","journal-title":"The Journal of Peptide Research"},{"key":"679_CR28","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.tips.2010.11.005","volume":"32","author":"WP Verdurmen","year":"2011","unstructured":"Verdurmen, W. P., & Brock, R. (2011). Biological responses towards cationic peptides and drug carriers. Trends in Pharmacological Sciences, 32, 116\u2013124.","journal-title":"Trends in Pharmacological Sciences"},{"key":"679_CR29","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.drudis.2012.03.002","volume":"17","author":"F Milletti","year":"2012","unstructured":"Milletti, F. (2012). Cell-penetrating peptides: Classes, origin, and current landscape. Drug Discovery Today, 17, 850\u2013860.","journal-title":"Drug Discovery Today"},{"key":"679_CR30","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/sj.mt.6300346","volume":"16","author":"HJ Johansson","year":"2008","unstructured":"Johansson, H. J., El-Andaloussi, S., Holm, T., M\u00e4e, M., J\u00e4nes, J., Maimets, T., & Langel, U. (2008). Characterization of a novel cytotoxic cell-penetrating peptide derived from p14ARF protein. Molecular Therapy, 16, 115\u2013123.","journal-title":"Molecular Therapy"},{"key":"679_CR31","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.bbrc.2006.07.065","volume":"348","author":"M Magzoub","year":"2006","unstructured":"Magzoub, M., Sandgren, S., Lundberg, P., Ogl\u0119cka, K., Lilja, J., Wittrup, A., Eriksson, L. E. G., Langel, U., Belting, M., & Graslund, A. (2006). N-terminal peptides from unprocessed prion proteins enter cells by macropinocytosis. Biochemical and Biophysical Research Communications, 348, 379\u2013385.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"679_CR32","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0006-291X(02)02595-0","volume":"299","author":"P Lundberg","year":"2002","unstructured":"Lundberg, P., Magzoub, M., Lindberg, M., H\u00e4llbrink, M., Jarvet, J., Eriksson, L., Langel, U., & Graslund, A. (2002). Cell membrane translocation of the N-terminal (1\u201328) part of the prion protein. Biochemical and Biophysical Research Communications, 299, 85\u201390.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"679_CR33","doi-asserted-by":"publisher","first-page":"414729","DOI":"10.1155\/2011\/414729","volume":"2011","author":"F Madani","year":"2011","unstructured":"Madani, F., Lindberg, S., Langel, \u00dc., Futaki, S., & Gr\u00e4slund, A. (2011). Mechanisms of cellular uptake of cell-penetrating peptides. Journal of Biophysics, 2011, 414729.","journal-title":"Journal of Biophysics"},{"key":"679_CR34","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0005-2736(02)00373-5","volume":"1563","author":"M Magzoub","year":"2002","unstructured":"Magzoub, M., Eriksson, L. G., & Gr\u00e4slund, A. (2002). Conformational states of the cell-penetrating peptide penetratin when interacting with phospholipid vesicles: Effects of surface charge and peptide concentration. Biochimica Et Biophysica Acta (BBA)-Biomembranes, 1563, 53\u201363.","journal-title":"Biochimica Et Biophysica Acta (BBA)-Biomembranes"},{"key":"679_CR35","doi-asserted-by":"publisher","first-page":"987","DOI":"10.3390\/pharmaceutics13070987","volume":"13","author":"\u00dc Langel","year":"2021","unstructured":"Langel, \u00dc. (2021). Cell-penetrating peptides and transportan. Pharmaceutics, 13, 987.","journal-title":"Pharmaceutics"},{"key":"679_CR36","doi-asserted-by":"publisher","first-page":"3654","DOI":"10.3390\/molecules24203654","volume":"24","author":"M Moiola","year":"2019","unstructured":"Moiola, M., Memeo, M. G., & Quadrelli, P. (2019). Stapled peptides-a useful improvement for peptide-based drugs. Molecules, 24, 3654.","journal-title":"Molecules"},{"key":"679_CR37","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.bmcl.2009.11.026","volume":"20","author":"JW Wollack","year":"2010","unstructured":"Wollack, J. W., Zeliadt, N. A., Ochocki, J. D., Mullen, D. G., Barany, G., Wattenberg, E. V., & Distefano, M. D. (2010). Investigation of the sequence and length dependence for cell-penetrating prenylated peptides. Bioorganic & Medicinal Chemistry Letters, 20, 161\u2013163.","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"key":"679_CR38","first-page":"191","volume-title":"Pepducins and other lipidated peptides as mechanistic probes and therapeutics","author":"P Zhang","year":"2015","unstructured":"Zhang, P., Covic, L., & Kuliopulos, A. (2015). Pepducins and other lipidated peptides as mechanistic probes and therapeutics (pp. 191\u2013203). Springer."},{"key":"679_CR39","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1021\/cb100423u","volume":"6","author":"S Gao","year":"2011","unstructured":"Gao, S., Simon, M. J., Hue, C. D., Morrison, B., & Banta, S. (2011). An unusual cell penetrating peptide identified using a plasmid display-based functional selection platform. ACS Chemical Biology, 6, 484\u2013491.","journal-title":"ACS Chemical Biology"},{"key":"679_CR40","doi-asserted-by":"publisher","first-page":"4057","DOI":"10.1016\/S0968-0896(02)00340-1","volume":"10","author":"C Gao","year":"2002","unstructured":"Gao, C., Mao, S., Ditzel, H. J., Farnaes, L., Wirsching, P., Lerner, R. A., & Janda, K. D. (2002). A cell-penetrating peptide from a novel pVII\u2013pIX phage-displayed random peptide library. Bioorganic & Medicinal Chemistry, 10, 4057\u20134065.","journal-title":"Bioorganic & Medicinal Chemistry"},{"key":"679_CR41","doi-asserted-by":"publisher","first-page":"25823","DOI":"10.1074\/jbc.M110.198267","volume":"286","author":"F Nakayama","year":"2011","unstructured":"Nakayama, F., Yasuda, T., Umeda, S., Asada, M., Imamura, T., Meineke, V., & Akashi, M. (2011). Fibroblast growth factor-12 (FGF12) translocation into intestinal epithelial cells is dependent on a novel cell-penetrating peptide domain: Involvement of internalization in the in vivo role of exogenous FGF12. Journal of Biological Chemistry, 286, 25823\u201325834.","journal-title":"Journal of Biological Chemistry"},{"key":"679_CR42","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.bbamem.2006.01.006","volume":"1758","author":"S Pujals","year":"2006","unstructured":"Pujals, S., Fern\u00e1ndez-Carneado, J., L\u00f3pez-Iglesias, C., Kogan, M. J., & Giralt, E. (2006). Mechanistic aspects of CPP-mediated intracellular drug delivery: relevance of CPP self-assembly. Biochimica et Biophysica Acta (BBA)-Biomembranes, 1758, 264\u2013279.","journal-title":"Biochimica et Biophysica Acta (BBA)-Biomembranes"},{"key":"679_CR43","doi-asserted-by":"publisher","first-page":"3597","DOI":"10.2174\/138161205774580796","volume":"11","author":"S El-Andaloussi","year":"2005","unstructured":"El-Andaloussi, S., Holm, T., & Langel, U. (2005). Cell-penetrating peptides: Mechanisms and applications. Current Pharmaceutical Design, 11, 3597\u20133611.","journal-title":"Current Pharmaceutical Design"},{"key":"679_CR44","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jconrel.2008.11.025","volume":"134","author":"M M\u00e4e","year":"2009","unstructured":"M\u00e4e, M., Andaloussi, S. E., Lundin, P., Oskolkov, N., Johansson, H. J., Guterstam, P., & Langel, U. (2009). A stearylated CPP for delivery of splice correcting oligonucleotides using a non-covalent co-incubation strategy. Journal of Controlled Release, 134, 221\u2013227.","journal-title":"Journal of Controlled Release"},{"key":"679_CR45","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.bbamem.2006.02.006","volume":"1758","author":"E Gros","year":"2006","unstructured":"Gros, E., Deshayes, S., Morris, M. C., Aldrian-Herrada, G., Depollier, J., Heitz, F., & Divita, G. (2006). A non-covalent peptide-based strategy for protein and peptide nucleic acid transduction. Biochimica et Biophysica Acta (BBA)-Biomembranes, 1758, 384\u2013393.","journal-title":"Biochimica et Biophysica Acta (BBA)-Biomembranes"},{"key":"679_CR46","doi-asserted-by":"publisher","first-page":"16010","DOI":"10.1074\/jbc.272.25.16010","volume":"272","author":"E Vives","year":"1997","unstructured":"Vives, E., Brodin, P., & Lebleu, B. (1997). A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. Journal of Biological Chemistry, 272, 16010\u201316017.","journal-title":"Journal of Biological Chemistry"},{"key":"679_CR47","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1006\/excr.2001.5316","volume":"269","author":"A Elmquist","year":"2001","unstructured":"Elmquist, A., Lindgren, M., Bartfai, T., & Langel, \u00dc. (2001). VE-cadherin-derived cell-penetrating peptide, pVEC, with carrier functions. Experimental Cell Research, 269, 237\u2013244.","journal-title":"Experimental Cell Research"},{"key":"679_CR48","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/S0962-8924(98)80017-2","volume":"8","author":"D Derossi","year":"1998","unstructured":"Derossi, D., Chassaing, G., & Prochiantz, A. (1998). Trojan peptides: The penetratin system for intracellular delivery. Trends in Cell Biology, 8, 84\u201387.","journal-title":"Trends in Cell Biology"},{"key":"679_CR49","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0092-8674(00)81843-7","volume":"88","author":"G Elliott","year":"1997","unstructured":"Elliott, G., & O\u2019Hare, P. (1997). Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell, 88, 223\u2013233.","journal-title":"Cell"},{"key":"679_CR50","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1096\/fasebj.12.1.67","volume":"12","author":"M Pooga","year":"1998","unstructured":"Pooga, M., H\u00e4llbrink, M., Zorko, M., & Langel, \u00dc. (1998). Cell penetration by transportan. The FASEB Journal, 12, 67\u201377.","journal-title":"The FASEB Journal"},{"key":"679_CR51","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/nbt1201-1173","volume":"19","author":"MC Morris","year":"2001","unstructured":"Morris, M. C., Depollier, J., Mery, J., Heitz, F., & Divita, G. (2001). A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nature Biotechnology, 19, 1173\u20131176.","journal-title":"Nature Biotechnology"},{"key":"679_CR52","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/mt.2008.215","volume":"17","author":"L Crombez","year":"2009","unstructured":"Crombez, L., Aldrian-Herrada, G., Konate, K., Nguyen, Q. N., McMaster, G. K., Brasseur, R., Heitz, F., & Divita, G. (2009). A new potent secondary amphipathic cell-penetrating peptide for siRNA delivery into mammalian cells. Molecular Therapy, 17, 95\u2013103.","journal-title":"Molecular Therapy"},{"key":"679_CR53","doi-asserted-by":"publisher","first-page":"6418","DOI":"10.1093\/nar\/gkn671","volume":"36","author":"GD Ivanova","year":"2008","unstructured":"Ivanova, G. D., Arzumanov, A., Abes, R., Yin, H., Wood, M. J., Lebleu, B., & Gait, M. J. (2008). Improved cell-penetrating peptide\u2013PNA conjugates for splicing redirection in HeLa cells and exon skipping in mdx mouse muscle. Nucleic Acids Research, 36, 6418\u20136428.","journal-title":"Nucleic Acids Research"},{"key":"679_CR54","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/S0005-2736(97)00141-7","volume":"1330","author":"J Oehlke","year":"1997","unstructured":"Oehlke, J., Beyermann, M., Wiesner, B., Melzig, M., Berger, H., Krause, E., & Bienert, M. (1997). Evidence for extensive and non-specific translocation of oligopeptides across plasma membranes of mammalian cells. Biochimica et Biophysica Acta (BBA)-Biomembranes, 1330, 50\u201360.","journal-title":"Biochimica et Biophysica Acta (BBA)-Biomembranes"},{"key":"679_CR55","doi-asserted-by":"publisher","first-page":"6043","DOI":"10.1046\/j.1432-1327.2000.01681.x","volume":"267","author":"A Scheller","year":"2000","unstructured":"Scheller, A., Wiesner, B., Melzig, M., Bienert, M., & Oehlke, J. (2000). Evidence for an amphipathicity independent cellular uptake of amphipathic cell-penetrating peptides. European Journal of Biochemistry, 267, 6043\u20136050.","journal-title":"European Journal of Biochemistry"},{"key":"679_CR56","doi-asserted-by":"publisher","first-page":"e16768","DOI":"10.1002\/aic.16768","volume":"65","author":"Z Gong","year":"2019","unstructured":"Gong, Z., Doolin, M. T., Adhikari, S., Stroka, K. M., & Karlsson, A. J. (2019). Role of charge and hydrophobicity in translocation of cell-penetrating peptides into Candida albicans cells. AIChE Journal, 65, e16768.","journal-title":"AIChE Journal"},{"key":"679_CR57","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.bbamem.2011.12.028","volume":"1818","author":"M Anko","year":"2012","unstructured":"Anko, M., Majhenc, J., Kogej, K., Sillard, R., Langel, \u00dc., Anderluh, G., & Zorko, M. (2012). Influence of stearyl and trifluoromethylquinoline modifications of the cell penetrating peptide TP10 on its interaction with a lipid membrane. Biochimica et Biophysica Acta (BBA)-Biomembranes, 1818, 915\u2013924.","journal-title":"Biochimica et Biophysica Acta (BBA)-Biomembranes"},{"key":"679_CR58","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0005-2736(98)00161-8","volume":"1414","author":"J Oehlke","year":"1998","unstructured":"Oehlke, J., Scheller, A., Wiesner, B., Krause, E., Beyermann, M., Klauschenz, E., Melzig, M., & Bienert, M. (1998). Cellular uptake of an \u03b1-helical amphipathic model peptide with the potential to deliver polar compounds into the cell interior non-endocytically. Biochimica et Biophysica Acta (BBA)-Biomembranes, 1414, 127\u2013139.","journal-title":"Biochimica et Biophysica Acta (BBA)-Biomembranes"},{"key":"679_CR59","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1042\/BC20060123","volume":"99","author":"S Gerbal-Chaloin","year":"2007","unstructured":"Gerbal-Chaloin, S., Gondeau, C., Aldrian-Herrada, G., Heitz, F., Gauthier-Rouvi\u00e8re, C., & Divita, G. (2007). First step of the cell-penetrating peptide mechanism involves Rac1 GTPase-dependent actin-network remodelling. Biology of the Cell, 99, 223\u2013238.","journal-title":"Biology of the Cell"},{"key":"679_CR60","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1006\/bbrc.1996.0071","volume":"218","author":"CB Park","year":"1996","unstructured":"Park, C. B., Kim, M. S., & Kim, S. C. (1996). A novel antimicrobial peptide frombufo bufo gargarizans. Biochemical and Biophysical Research Communications, 218, 408\u2013413.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"679_CR61","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0022-3565(24)29672-5","volume":"296","author":"C Rousselle","year":"2001","unstructured":"Rousselle, C., Smirnova, M., Clair, P., Lefauconnier, J. M., Chavanieu, A., Calas, B., Scherrmann, J. M., & Temsamani, J. (2001). Enhanced delivery of doxorubicin into the brain via a peptide-vector-mediated strategy: Saturation kinetics and specificity. Journal of Pharmacology and Experimental Therapeutics, 296, 124\u2013131.","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"679_CR62","first-page":"303","volume-title":"PepFects and NickFects for the intracellular delivery of nucleic acids","author":"P Arukuusk","year":"2015","unstructured":"Arukuusk, P., P\u00e4rnaste, L., H\u00e4llbrink, M., & Langel, \u00dc. (2015). PepFects and NickFects for the intracellular delivery of nucleic acids (pp. 303\u2013315). Springer."},{"key":"679_CR63","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/S0014-5793(97)01123-X","volume":"415","author":"J Oehlke","year":"1997","unstructured":"Oehlke, J., Krause, E., Wiesner, B., Beyermann, M., & Bienert, M. (1997). Extensive cellular uptake into endothelial cells of an amphipathic \u03b2-sheet forming peptide. FEBS Letters, 415, 196\u2013199.","journal-title":"FEBS Letters"},{"key":"679_CR64","doi-asserted-by":"publisher","first-page":"3008","DOI":"10.1021\/bi9618474","volume":"36","author":"TB Wyman","year":"1997","unstructured":"Wyman, T. B., Nicol, F., Zelphati, O., Scaria, P., Plank, C., & Szoka, F. C. (1997). Design, synthesis, and characterization of a cationic peptide that binds to nucleic acids and permeabilizes bilayers. Biochemistry, 36, 3008\u20133017.","journal-title":"Biochemistry"},{"key":"679_CR65","doi-asserted-by":"publisher","first-page":"14255","DOI":"10.1074\/jbc.270.24.14255","volume":"270","author":"YZ Lin","year":"1995","unstructured":"Lin, Y. Z., Yao, S., Veach, R. A., Torgerson, T. R., & Hawiger, J. (1995). Inhibition of nuclear translocation of transcription factor NF-\u03baB by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. Journal of Biological Chemistry, 270, 14255\u201314258.","journal-title":"Journal of Biological Chemistry"},{"key":"679_CR66","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1074\/jbc.M509813200","volume":"281","author":"M Rhee","year":"2006","unstructured":"Rhee, M., & Davis, P. (2006). Mechanism of uptake of C105Y, a novel cell-penetrating peptide. Journal of Biological Chemistry, 281, 1233\u20131240.","journal-title":"Journal of Biological Chemistry"},{"key":"679_CR67","doi-asserted-by":"publisher","first-page":"5337","DOI":"10.1007\/s00044-013-0538-z","volume":"22","author":"YC Hsiao","year":"2013","unstructured":"Hsiao, Y. C., Lee, C. Y., Lin, Y. J., Tsai, S. H., Jeng, K. C. G., Chao, W. T., & Lung, F. D. T. (2013). Design, synthesis, and evaluation of fluorescent cell-penetrating peptidic antagonists of Grb2-SH2 for targeting MCF-7 breast cancer cells. Medicinal Chemistry Research, 22, 5337\u20135343.","journal-title":"Medicinal Chemistry Research"},{"key":"679_CR68","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1042\/BST0350797","volume":"35","author":"J Gomez","year":"2007","unstructured":"Gomez, J., Gama, V., Yoshida, T., Sun, W., Hayes, P., Leskov, K., Boothman, D., & Matsuyama, S. (2007). Bax-inhibiting peptides derived from Ku70 and cell-penetrating pentapeptides. Biochemical Society Transactions, 35, 797\u2013801.","journal-title":"Biochemical Society Transactions"},{"key":"679_CR69","doi-asserted-by":"publisher","first-page":"6056","DOI":"10.1021\/acsomega.8b00483","volume":"3","author":"PK Lai","year":"2018","unstructured":"Lai, P. K., & Kaznessis, Y. N. (2018). Insights into membrane translocation of protegrin antimicrobial peptides by multistep molecular dynamics simulations. ACS Omega, 3, 6056\u20136065.","journal-title":"ACS Omega"},{"key":"679_CR70","doi-asserted-by":"publisher","first-page":"36099","DOI":"10.1074\/jbc.M109.036426","volume":"284","author":"F Duchardt","year":"2009","unstructured":"Duchardt, F., Ruttekolk, I. R., Verdurmen, W. P., Lortat-Jacob, H., B\u00fcrck, J., Hufnagel, H., Fischer, R., van den Heuvel, M., Lowik, D. W. P. M., Vuister, G. W., Ulrich, A., Waard, M., & Brock, R. (2009). A cell-penetrating peptide derived from human lactoferrin with conformation-dependent uptake efficiency. Journal of Biological Chemistry, 284, 36099\u201336108.","journal-title":"Journal of Biological Chemistry"},{"key":"679_CR71","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1016\/j.bbamem.2009.12.011","volume":"1798","author":"X Zhang","year":"2010","unstructured":"Zhang, X., Ogl\u0119cka, K., Sandgren, S., Belting, M., Esbj\u00f6rner, E. K., Nord\u00e9n, B., & Graslund, A. (2010). Dual functions of the human antimicrobial peptide LL-37-target membrane perturbation and host cell cargo delivery. Biochimica et Biophysica Acta (BBA)- Biomembranes, 1798, 2201\u20132208.","journal-title":"Biochimica et Biophysica Acta (BBA)- Biomembranes"},{"key":"679_CR72","doi-asserted-by":"publisher","first-page":"14150","DOI":"10.1021\/bi026661l","volume":"41","author":"K Sadler","year":"2002","unstructured":"Sadler, K., Eom, K. D., Yang, J. L., Dimitrova, Y., & Tam, J. P. (2002). Translocating proline-rich peptides from the antimicrobial peptide bactenecin 7. Biochemistry, 41, 14150\u201314157.","journal-title":"Biochemistry"},{"key":"679_CR73","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0095939","volume":"9","author":"EJ Veldhuizen","year":"2014","unstructured":"Veldhuizen, E. J., Schneider, V. A., Agustiandari, H., Van Dijk, A., Tjeerdsma-van Bokhoven, J. L., Bikker, F. J., & Haagsman, H. P. (2014). Antimicrobial and immunomodulatory activities of PR-39 derived peptides. PLoS ONE, 9, e95939.","journal-title":"PLoS ONE"},{"key":"679_CR74","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1016\/j.bbamem.2016.05.021","volume":"1858","author":"J Franz","year":"2016","unstructured":"Franz, J., Lelle, M., Peneva, K., Bonn, M., & Weidner, T. (2016). SAP (E)-A cell-penetrating polyproline helix at lipid interfaces. Biochimica et Biophysica Acta (BBA)-Biomembranes, 1858, 2028\u20132034.","journal-title":"Biochimica et Biophysica Acta (BBA)-Biomembranes"},{"key":"679_CR75","doi-asserted-by":"crossref","unstructured":"Wyatt, L.C., Moshnikova, A., Crawford, T., Engelman, D.M., Andreev, O.A., & Reshetnyak, Y.K. (2018). Peptides of pHLIP family for targeted intracellular and extracellular delivery of cargo molecules to tumors. Proceedings of the National Academy of Sciences, 115, E2811-E2818","DOI":"10.1073\/pnas.1715350115"},{"key":"679_CR76","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.addr.2003.10.041","volume":"56","author":"W Li","year":"2004","unstructured":"Li, W., Nicol, F., & Szoka, F. C., Jr. (2004). GALA: A designed synthetic pH-responsive amphipathic peptide with applications in drug and gene delivery. Advanced Drug Delivery Reviews, 56, 967\u2013985.","journal-title":"Advanced Drug Delivery Reviews"},{"key":"679_CR77","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/bip.22638","volume":"103","author":"A Namvar","year":"2015","unstructured":"Namvar, A., Bolhassani, A., Khairkhah, N., & Motevalli, F. (2015). Physicochemical properties of polymers: An important system to overcome the cell barriers in gene transfection. Biopolymers, 103, 363\u2013375.","journal-title":"Biopolymers"},{"key":"679_CR78","doi-asserted-by":"publisher","first-page":"197986","DOI":"10.1016\/j.virusres.2020.197986","volume":"284","author":"GAP de Souza","year":"2020","unstructured":"de Souza, G. A. P., Salvador, E. A., de Oliveira, F. R., Malaquias, L. C. C., Abrah\u00e3o, J. S., & Coelho, L. F. L. (2020). An in silico integrative protocol for identifying key genes and pathways useful to understand emerging virus disease pathogenesis. Virus Research, 284, 197986.","journal-title":"Virus Research"},{"key":"679_CR79","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1080\/17425247.2019.1676720","volume":"16","author":"K Kardani","year":"2019","unstructured":"Kardani, K., Milani, A., Shabani, H., & S., & Bolhassani, A. (2019). Cell penetrating peptides: The potent multi-cargo intracellular carriers. Expert Opinion on Drug Delivery, 16, 1227\u20131258.","journal-title":"Expert Opinion on Drug Delivery"},{"key":"679_CR80","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.addr.2009.06.001","volume":"61","author":"SB Fonseca","year":"2009","unstructured":"Fonseca, S. B., Pereira, M. P., & Kelley, S. O. (2009). Recent advances in the use of cell-penetrating peptides for medical and biological applications. Advanced Drug Delivery Reviews, 61, 953\u2013964.","journal-title":"Advanced Drug Delivery Reviews"},{"key":"679_CR81","doi-asserted-by":"publisher","first-page":"14051","DOI":"10.3390\/molecules200814051","volume":"20","author":"S Szunerits","year":"2015","unstructured":"Szunerits, S., Barras, A., Khanal, M., Pagneux, Q., & Boukherroub, R. (2015). Nanostructures for the inhibition of viral infections. Molecules, 20, 14051\u201314081.","journal-title":"Molecules"},{"key":"679_CR82","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.peptides.2016.11.011","volume":"87","author":"A Bolhassani","year":"2017","unstructured":"Bolhassani, A., Jafarzade, B. S., & Mardani, G. (2017). In vitro and in vivo delivery of therapeutic proteins using cell penetrating peptides. Peptides, 87, 50\u201363.","journal-title":"Peptides"},{"key":"679_CR83","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.3389\/fmicb.2019.02725","volume":"10","author":"L Wang","year":"2019","unstructured":"Wang, L., Liang, R., Gao, Y., Li, Y., Deng, X., Xiang, R., Zhang, Y., Ying, T., Jiang, S., & Yu, F. (2019). Development of small-molecule inhibitors against Zika virus infection. Frontiers in Microbiology, 10, 2725.","journal-title":"Frontiers in Microbiology"},{"key":"679_CR84","doi-asserted-by":"crossref","unstructured":"Yang, N.J., & Hinner, M.J. (2015). Getting across the cell membrane: an overview for small molecules, peptides, and proteins. Site-specific Protein Labeling, pp: 29\u201353","DOI":"10.1007\/978-1-4939-2272-7_3"},{"key":"679_CR85","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1517\/17425240902939143","volume":"6","author":"E Barbu","year":"2009","unstructured":"Barbu, E., Moln\u00e0r, \u00c9., Tsibouklis, J., & G\u00f3recki, D. C. (2009). The potential for nanoparticle-based drug delivery to the brain: Overcoming the blood-brain barrier. Expert Opinion on Drug Delivery, 6, 553\u2013565.","journal-title":"Expert Opinion on Drug Delivery"},{"key":"679_CR86","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1002\/bip.20989","volume":"90","author":"VP Torchilin","year":"2008","unstructured":"Torchilin, V. P. (2008). Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery. Peptide Science, 90, 604\u2013610.","journal-title":"Peptide Science"},{"key":"679_CR87","doi-asserted-by":"publisher","first-page":"33","DOI":"10.4110\/in.2016.16.1.33","volume":"16","author":"S Lim","year":"2016","unstructured":"Lim, S., Koo, J. H., & Choi, J. M. (2016). Use of cell-penetrating peptides in dendritic cell-based vaccination. Immune Network, 16, 33\u201343.","journal-title":"Immune Network"},{"key":"679_CR88","doi-asserted-by":"publisher","first-page":"256","DOI":"10.2174\/1389201015666140813130114","volume":"15","author":"Y Jiang","year":"2014","unstructured":"Jiang, Y., Li, M., Zhang, Z., Gong, T., & Sun, X. (2014). Cell-penetrating peptides as delivery enhancers for vaccine. Current Pharmaceutical Biotechnology, 15, 256\u2013266.","journal-title":"Current Pharmaceutical Biotechnology"},{"key":"679_CR89","doi-asserted-by":"publisher","first-page":"14033","DOI":"10.3390\/molecules200814033","volume":"20","author":"N Brooks","year":"2015","unstructured":"Brooks, N., Esparon, S., Pouniotis, D., & Pietersz, G. A. (2015). Comparative immunogenicity of a cytotoxic T cell epitope delivered by penetratin and TAT cell penetrating peptides. Molecules, 20, 14033\u201314050.","journal-title":"Molecules"},{"key":"679_CR90","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3390\/ijms17020185","volume":"17","author":"M Kristensen","year":"2016","unstructured":"Kristensen, M., Birch, D., & M\u00f8rck Nielsen, H. (2016). Applications and challenges for use of cell-penetrating peptides as delivery vectors for peptide and protein cargos. International Journal of Molecular Sciences, 17, 185.","journal-title":"International Journal of Molecular Sciences"},{"key":"679_CR91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12929-019-0592-z","volume":"27","author":"RM Lu","year":"2020","unstructured":"Lu, R. M., Hwang, Y. C., Liu, I. J., Lee, C. C., Tsai, H. Z., Li, H. J., & Wu, H. C. (2020). Development of therapeutic antibodies for the treatment of diseases. Journal of Biomedical Science, 27, 1\u201330.","journal-title":"Journal of Biomedical Science"},{"key":"679_CR92","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1007\/s00259-006-0189-0","volume":"34","author":"M Hu","year":"2007","unstructured":"Hu, M., Chen, P., Wang, J., Scollard, D. A., Vallis, K. A., & Reilly, R. M. (2007). 123I-labeled HIV-1 tat peptide radioimmunoconjugates are imported into the nucleus of human breast cancer cells and functionally interact in vitro and in vivo with the cyclin-dependent kinase inhibitor, p21WAF-1\/Cip-1. European Journal of Nuclear Medicine and Molecular Imaging, 34, 368\u2013377.","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"key":"679_CR93","doi-asserted-by":"publisher","first-page":"e0145986","DOI":"10.1371\/journal.pone.0145986","volume":"11","author":"SA Ali","year":"2016","unstructured":"Ali, S. A., Teow, S. Y., Omar, T. C., Khoo, A. S. B., Choon, T. S., & Yusoff, N. M. (2016). A cell internalizing antibody targeting capsid protein (p24) inhibits the replication of HIV-1 in T cells lines and PBMCS: A proof of concept study. PLoS ONE, 11, e0145986.","journal-title":"PLoS ONE"},{"key":"679_CR94","doi-asserted-by":"publisher","first-page":"549","DOI":"10.7150\/thno.20047","volume":"8","author":"JF Zhang","year":"2018","unstructured":"Zhang, J. F., Xiong, H. L., Cao, J. L., Wang, S. J., Guo, X. R., Lin, B. Y., Zhang, Y., Zhao, J. H., Wang, Y. B., Zhang, T. Y., Yuan, Q., Zhang, J., & Xia, N. S. (2018). A cell-penetrating whole molecule antibody targeting intracellular HBx suppresses hepatitis B virus via TRIM21-dependent pathway. Theranostics, 8, 549.","journal-title":"Theranostics"},{"key":"679_CR95","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s00425-013-2019-5","volume":"239","author":"S Saurabh","year":"2014","unstructured":"Saurabh, S., Vidyarthi, A. S., & Prasad, D. (2014). RNA interference: Concept to reality in crop improvement. Planta, 239, 543\u2013564.","journal-title":"Planta"},{"key":"679_CR96","doi-asserted-by":"publisher","first-page":"E18","DOI":"10.1208\/aapsj0901003","volume":"9","author":"ME Martin","year":"2007","unstructured":"Martin, M. E., & Rice, K. G. (2007). Peptide-guided gene delivery. The AAPS Journal, 9, E18\u2013E29.","journal-title":"The AAPS Journal"},{"key":"679_CR97","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.jconrel.2005.09.036","volume":"109","author":"E Kleemann","year":"2005","unstructured":"Kleemann, E., Neu, M., Jekel, N., Fink, L., Schmehl, T., Gessler, T., Seeget, W., & Kissel, T. (2005). Nano-carriers for DNA delivery to the lung based upon a TAT-derived peptide covalently coupled to PEG\u2013PEI. Journal of Controlled Release, 109, 299\u2013316.","journal-title":"Journal of Controlled Release"},{"key":"679_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-020-0207-x","volume":"5","author":"B Hu","year":"2020","unstructured":"Hu, B., Zhong, L., Weng, Y., Peng, L., Huang, Y., Zhao, Y., & Liang, X. J. (2020). Therapeutic siRNA: State of the art. Signal Transduction and Targeted Therapy, 5, 1\u201325.","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"679_CR99","doi-asserted-by":"publisher","first-page":"102638","DOI":"10.1016\/j.cis.2022.102638","volume":"302","author":"J Wang","year":"2022","unstructured":"Wang, J., Chen, G., Liu, N., Han, X., Zhao, F., Zhang, L., & Chen, P. (2022). Strategies for improving the safety and RNAi efficacy of noncovalent peptide\/siRNA nanocomplexes. Advances in Colloid and Interface Science, 302, 102638.","journal-title":"Advances in Colloid and Interface Science"},{"key":"679_CR100","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1080\/10717544.2018.1543366","volume":"25","author":"T Singh","year":"2018","unstructured":"Singh, T., Murthy, A. S., Yang, H. J., & Im, J. (2018). Versatility of cell-penetrating peptides for intracellular delivery of siRNA. Drug Delivery, 25, 1996\u20132006.","journal-title":"Drug Delivery"},{"key":"679_CR101","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1042\/BST0350044","volume":"35","author":"L Crombez","year":"2007","unstructured":"Crombez, L., Charnet, A., Morris, M. C., Aldrian-Herrada, G., Heitz, F., & Divita, G. (2007). A non-covalent peptide-based strategy for siRNA delivery. Biochemical Society Transactions, 35, 44\u201346.","journal-title":"Biochemical Society Transactions"},{"key":"679_CR102","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1128\/AAC.00011-08","volume":"52","author":"JK Stone","year":"2008","unstructured":"Stone, J. K., Rijnbrand, R., Stein, D. A., Ma, Y., Yang, Y., Iversen, P. L., & Andino, R. (2008). A morpholino oligomer targeting highly conserved internal ribosome entry site sequence is able to inhibit multiple species of picornavirus. Antimicrobial Agents and Chemotherapy, 52, 1970\u20131981.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"679_CR103","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1128\/AAC.00936-08","volume":"53","author":"DL Swenson","year":"2009","unstructured":"Swenson, D. L., Warfield, K. L., Warren, T. K., Lovejoy, C., Hassinger, J. N., Ruthel, G., Blouch, R. E., Moulton, H. M., Weller, D. D., Iversen, P. L., & Bavari, S. (2009). Chemical modifications of antisense morpholino oligomers enhance their efficacy against Ebola virus infection. Antimicrobial Agents and Chemotherapy, 53, 2089\u20132099.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"679_CR104","doi-asserted-by":"publisher","first-page":"9665","DOI":"10.1128\/JVI.79.15.9665-9676.2005","volume":"79","author":"BW Neuman","year":"2005","unstructured":"Neuman, B. W., Stein, D. A., Kroeker, A. D., Churchill, M. J., Kim, A. M., Kuhn, P., Dawson, P., Moulton, H. M., Bestwick, R. K., Iversen, P. L., & Buchmeier, M. J. (2005). Inhibition, escape, and attenuated growth of severe acute respiratory syndrome coronavirus treated with antisense morpholino oligomers. Journal of Virology, 79, 9665\u20139676.","journal-title":"Journal of Virology"},{"key":"679_CR105","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.antiviral.2009.07.020","volume":"84","author":"M Moerdyk-Schauwecker","year":"2009","unstructured":"Moerdyk-Schauwecker, M., Stein, D. A., Eide, K., Blouch, R. E., Bildfell, R., Iversen, P., & Jin, L. (2009). Inhibition of HSV-1 ocular infection with morpholino oligomers targeting ICP0 and ICP27. Antiviral Research, 84, 131\u2013141.","journal-title":"Antiviral Research"},{"key":"679_CR106","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.virol.2007.01.016","volume":"363","author":"S Tripathi","year":"2007","unstructured":"Tripathi, S., Chaubey, B., Barton, B. E., & Pandey, V. N. (2007). Anti HIV-1 virucidal activity of polyamide nucleic acid-membrane transducing peptide conjugates targeted to primer binding site of HIV-1 genome. Virology, 363, 91\u2013103.","journal-title":"Virology"},{"key":"679_CR107","doi-asserted-by":"publisher","first-page":"e298","DOI":"10.1111\/j.1365-2893.2010.01416.x","volume":"18","author":"DG Ahn","year":"2011","unstructured":"Ahn, D. G., Shim, S. B., Moon, J. E., Kim, J. H., Kim, S. J., & Oh, J. W. (2011). Interference of hepatitis C virus replication in cell culture by antisense peptide nucleic acids targeting the X-RNA. Journal of Viral Hepatitis, 18, e298\u2013e306.","journal-title":"Journal of Viral Hepatitis"},{"key":"679_CR108","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.virusres.2008.10.018","volume":"140","author":"K Sleeman","year":"2009","unstructured":"Sleeman, K., Stein, D. A., Tamin, A., Reddish, M., Iversen, P. L., & Rota, P. A. (2009). Inhibition of measles virus infections in cell cultures by peptide-conjugated morpholino oligomers. Virus Research, 140, 49\u201356.","journal-title":"Virus Research"},{"key":"679_CR109","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.antiviral.2009.02.187","volume":"82","author":"JS Yoo","year":"2009","unstructured":"Yoo, J. S., Kim, C. M., Kim, J. H., Kim, J. Y., & Oh, J. W. (2009). Inhibition of Japanese encephalitis virus replication by peptide nucleic acids targeting cis-acting elements on the plus-and minus-strands of viral RNA. Antiviral Research, 82, 122\u2013133.","journal-title":"Antiviral Research"},{"key":"679_CR110","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1099\/vir.0.83449-0","volume":"89","author":"G Gabriel","year":"2008","unstructured":"Gabriel, G., Nordmann, A., Stein, D. A., Iversen, P. L., & Klenk, H. D. (2008). Morpholino oligomers targeting the PB1 and NP genes enhance the survival of mice infected with highly pathogenic influenza A H7N7 virus. Journal of General Virology, 89, 939\u2013948.","journal-title":"Journal of General Virology"},{"key":"679_CR111","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.chembiol.2005.06.009","volume":"12","author":"T Shiraishi","year":"2005","unstructured":"Shiraishi, T., Pankratova, S., & Nielsen, P. E. (2005). Calcium ions effectively enhance the effect of antisense peptide nucleic acids conjugated to cationic tat and oligoarginine peptides. Chemistry and Biology, 12, 923\u2013929.","journal-title":"Chemistry and Biology"},{"key":"679_CR112","doi-asserted-by":"publisher","first-page":"14944","DOI":"10.1021\/bi0606896","volume":"45","author":"Y Wolf","year":"2006","unstructured":"Wolf, Y., Pritz, S., Abes, S., Bienert, M., Lebleu, B., & Oehlke, J. (2006). Structural requirements for cellular uptake and antisense activity of peptide nucleic acids conjugated with various peptides. Biochemistry, 45, 14944\u201314954.","journal-title":"Biochemistry"},{"key":"679_CR113","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.addr.2009.04.005","volume":"61","author":"T Endoh","year":"2009","unstructured":"Endoh, T., & Ohtsuki, T. (2009). Cellular siRNA delivery using cell-penetrating peptides modified for endosomal escape. Advanced Drug Delivery Reviews, 61, 704\u2013709.","journal-title":"Advanced Drug Delivery Reviews"},{"key":"679_CR114","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.addr.2007.09.005","volume":"60","author":"S Deshayes","year":"2008","unstructured":"Deshayes, S., Morris, M., Heitz, F., & Divita, G. (2008). Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy. Advanced Drug Delivery Reviews, 60, 537\u2013547.","journal-title":"Advanced Drug Delivery Reviews"},{"key":"679_CR115","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.bbrc.2007.09.041","volume":"363","author":"WS Sung","year":"2007","unstructured":"Sung, W. S., Park, Y., Choi, C. H., Hahm, K. S., & Lee, D. G. (2007). Mode of antibacterial action of a signal peptide, Pep27 from Streptococcus pneumoniae. Biochemical and Biophysical Research Communications, 363, 806\u2013810.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"679_CR116","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1021\/acsinfecdis.0c00894","volume":"7","author":"HK Kang","year":"2021","unstructured":"Kang, H. K., Park, J., Seo, C. H., & Park, Y. (2021). PEP27-2, a potent antimicrobial cell-penetrating peptide, reduces skin abscess formation during Staphylococcus aureus infections in mouse when used in combination with antibiotics. ACS Infectious Diseases, 7, 2620\u20132636.","journal-title":"ACS Infectious Diseases"},{"key":"679_CR117","doi-asserted-by":"publisher","first-page":"349427","DOI":"10.1155\/2012\/349427","volume":"2012","author":"S Keogan","year":"2012","unstructured":"Keogan, S., Passic, S., & Krebs, F. C. (2012). Infection by CXCR4-tropic human immunodeficiency virus type 1 is inhibited by the cationic cell-penetrating peptide derived from HIV-1 tat. International Journal of Peptides, 2012, 349427.","journal-title":"International Journal of Peptides"},{"key":"679_CR118","doi-asserted-by":"publisher","first-page":"601555","DOI":"10.3389\/fmicb.2020.601555","volume":"11","author":"Z Ruzsics","year":"2020","unstructured":"Ruzsics, Z., Hoffmann, K., Riedl, A., Krawczyk, A., Widera, M., Sertznig, H., Schipper, L., Kapper-Falcone, V., Debreczeny, M., Ernst, W., Grabherr, R., Hengel, H., & Harant, H. (2020). A novel, broad-acting peptide inhibitor of double-stranded DNA virus gene expression and replication. Frontiers in Microbiology, 11, 601555.","journal-title":"Frontiers in Microbiology"},{"key":"679_CR119","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.virol.2004.10.032","volume":"331","author":"B Chaubey","year":"2005","unstructured":"Chaubey, B., Tripathi, S., Ganguly, S., Harris, D., Casale, R. A., & Pandey, V. N. (2005). A PNA-transportan conjugate targeted to the TAR region of the HIV-1 genome exhibits both antiviral and virucidal properties. Virology, 331, 418\u2013428.","journal-title":"Virology"},{"key":"679_CR120","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.antiviral.2010.12.001","volume":"89","author":"XB Pan","year":"2011","unstructured":"Pan, X. B., Wei, L., Han, J. C., Ma, H., Deng, K., & Cong, X. (2011). Artificial recombinant cell-penetrating peptides interfere with envelopment of hepatitis B virus nucleocapsid and viral production. Antiviral Research, 89, 109\u2013114.","journal-title":"Antiviral Research"},{"key":"679_CR121","doi-asserted-by":"publisher","first-page":"6121","DOI":"10.1073\/pnas.1917748117","volume":"117","author":"P Zhang","year":"2020","unstructured":"Zhang, P., Moreno, R., Lambert, P. F., & DiMaio, D. (2020). Cell-penetrating peptide inhibits retromer-mediated human papillomavirus trafficking during virus entry. Proceedings of the National Academy of Sciences, 117, 6121\u20136128.","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"679_CR122","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/4710","volume":"5","author":"AM Vocero-Akbani","year":"1999","unstructured":"Vocero-Akbani, A. M., Heyden, N. V., Lissy, N. A., Ratner, L., & Dowdy, S. F. (1999). Killing HIV-infected cells by transduction with an HIV protease-activated caspase-3 protein. Nature Medicine, 5, 29\u201333.","journal-title":"Nature Medicine"},{"key":"679_CR123","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.antiviral.2016.01.008","volume":"127","author":"X Chu","year":"2016","unstructured":"Chu, X., Wu, B., Fan, H., Hou, J., Hao, J., Hu, J., Wang, B., Liu, G., Li, C., & Meng, S. (2016). PTD-fused p53 as a potential antiviral agent directly suppresses HBV transcription and expression. Antiviral Research, 127, 41\u201349.","journal-title":"Antiviral Research"},{"key":"679_CR124","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.antiviral.2007.11.006","volume":"79","author":"N Darbinian","year":"2008","unstructured":"Darbinian, N., Popov, Y., Khalili, K., & Amini, S. (2008). Creation of a bi-directional protein transduction system for suppression of HIV-1 expression by p27SJ. Antiviral Research, 79, 136\u2013141.","journal-title":"Antiviral Research"},{"key":"679_CR125","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.antiviral.2013.05.009","volume":"99","author":"XM Zhang","year":"2013","unstructured":"Zhang, X. M., He, D. N., Zhou, B., Pang, R., Liu, K., Zhao, J., & Chen, P. (2013). In vitro inhibition of vesicular stomatitis virus replication by purified porcine Mx1 protein fused to HIV-1 Tat protein transduction domain (PTD). Antiviral Research, 99, 149\u2013157.","journal-title":"Antiviral Research"},{"key":"679_CR126","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1007\/s00705-008-0125-7","volume":"153","author":"T Mino","year":"2008","unstructured":"Mino, T., Mori, T., Aoyama, Y., & Sera, T. (2008). Cell-permeable artificial zinc-finger proteins as potent antiviral drugs for human papillomaviruses. Archives of Virology, 153, 1291\u20131298.","journal-title":"Archives of Virology"},{"key":"679_CR127","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1016\/j.vaccine.2006.01.055","volume":"24","author":"DM Theisen","year":"2006","unstructured":"Theisen, D. M., Pongratz, C., Wiegmann, K., Rivero, F., Krut, O., & Kr\u00f6nke, M. (2006). Targeting of HIV-1 Tat traffic and function by transduction-competent single chain antibodies. Vaccine, 24, 3127\u20133136.","journal-title":"Vaccine"},{"key":"679_CR128","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.intimp.2015.01.028","volume":"25","author":"Y Wang","year":"2015","unstructured":"Wang, Y., Li, Y., Li, N., Zhu, Q., Hui, L., Liu, X., Han, Q., Lv, Y., Wang, Q., Yang, G., Zhou, Z., & Liu, Z. (2015). Transbody against hepatitis B virus core protein inhibits hepatitis B virus replication in vitro. International Immunopharmacology, 25, 363\u2013369.","journal-title":"International Immunopharmacology"},{"key":"679_CR129","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-14886-9","volume":"7","author":"K Glab-Ampai","year":"2017","unstructured":"Glab-Ampai, K., Chulanetra, M., Malik, A. A., Juntadech, T., Thanongsaksrikul, J., Srimanote, P., & Chaicumpa, W. (2017). Human single chain-transbodies that bound to domain-I of non-structural protein 5A (NS5A) of hepatitis C virus. Scientific Reports, 7, 1\u201318.","journal-title":"Scientific Reports"},{"key":"679_CR130","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.bbrc.2016.05.109","volume":"476","author":"K Glab-Ampai","year":"2016","unstructured":"Glab-Ampai, K., Malik, A. A., Chulanetra, M., Thanongsaksrikul, J., Thueng-In, K., Srimanote, P., Tongtawe, P., & Chaicumpa, W. (2016). Inhibition of HCV replication by humanized-single domain transbodies to NS4B. Biochemical and Biophysical Research Communications, 476, 654\u2013664.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"679_CR131","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1021\/bc900251u","volume":"21","author":"O Poungpair","year":"2010","unstructured":"Poungpair, O., Pootong, A., Maneewatch, S., Srimanote, P., Tongtawe, P., Songserm, T., Tapchaisri, P., & Chaicumpa, W. (2010). A human single chain transbody specific to matrix protein (M1) interferes with the replication of influenza A virus. Bioconjugate Chemistry, 21, 1134\u20131141.","journal-title":"Bioconjugate Chemistry"},{"key":"679_CR132","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.bbrc.2016.09.052","volume":"479","author":"S Teimoori","year":"2016","unstructured":"Teimoori, S., Seesuay, W., Jittavisutthikul, S., Chaisri, U., Sookrung, N., Densumite, J., Saelim, N., Chulanetra, M., Maneewatch, S., & Chaicumpa, W. (2016). Human transbodies to VP40 inhibit cellular egress of Ebola virus-like particles. Biochemical and Biophysical Research Communications, 479, 245\u2013252.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"679_CR133","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1080\/1061186X.2016.1245311","volume":"25","author":"S Bivalkar-Mehla","year":"2017","unstructured":"Bivalkar-Mehla, S., Mehla, R., & Chauhan, A. (2017). Chimeric peptide-mediated siRNA transduction to inhibit HIV-1 infection. Journal of Drug Targeting, 25, 307\u2013319.","journal-title":"Journal of Drug Targeting"},{"key":"679_CR134","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.2147\/DDDT.S195481","volume":"13","author":"C Zhang","year":"2019","unstructured":"Zhang, C., Ren, W., Liu, Q., Tan, Z., Li, J., & Tong, C. (2019). Transportan-derived cell-penetrating peptide delivers siRNA to inhibit replication of influenza virus in vivo. Drug Design, Development and Therapy, 13, 1059.","journal-title":"Drug Design, Development and Therapy"},{"key":"679_CR135","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1159\/000220597","volume":"52","author":"S Meng","year":"2009","unstructured":"Meng, S., Wei, B., Xu, R., Zhang, K., Wang, L., Zhang, R., & Li, J. (2009). TAT peptides mediated small interfering RNA delivery to Huh-7 cells and efficiently inhibited hepatitis C virus RNA replication. Intervirology, 52, 135\u2013140.","journal-title":"Intervirology"},{"key":"679_CR136","doi-asserted-by":"publisher","first-page":"e295","DOI":"10.1038\/mtna.2016.11","volume":"5","author":"Z Zeng","year":"2016","unstructured":"Zeng, Z., Han, S., Hong, W., Lang, Y., Li, F., Liu, Y., Li, Z., Wu, Y., Li, W., Zhang, X., & Cao, Z. (2016). A Tat-conjugated peptide nucleic acid Tat-PNA-DR inhibits hepatitis B virus replication in vitro and in vivo by targeting LTR direct repeats of HBV RNA. Molecular Therapy-Nucleic Acids, 5, e295.","journal-title":"Molecular Therapy-Nucleic Acids"},{"key":"679_CR137","doi-asserted-by":"publisher","first-page":"6837","DOI":"10.1093\/nar\/gki991","volume":"33","author":"JJ Turner","year":"2005","unstructured":"Turner, J. J., Ivanova, G. D., Verbeure, B., Williams, D., Arzumanov, A. A., Abes, S., Lebleu, B., & Gait, M. J. (2005). Cell-penetrating peptide conjugates of peptide nucleic acids (PNA) as inhibitors of HIV-1 Tat-dependent trans-activation in cells. Nucleic Acids Research, 33, 6837\u20136849.","journal-title":"Nucleic Acids Research"},{"key":"679_CR138","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.antiviral.2011.04.009","volume":"91","author":"DG Ahn","year":"2011","unstructured":"Ahn, D. G., Lee, W., Choi, J. K., Kim, S. J., Plant, E. P., Almaz\u00e1n, F., Taylor, D. R., Enjuanes, L., & Oh, J. W. (2011). Interference of ribosomal frameshifting by antisense peptide nucleic acids suppresses SARS coronavirus replication. Antiviral Research, 91, 1\u201310.","journal-title":"Antiviral Research"},{"key":"679_CR139","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1128\/AAC.50.3.984-993.2006","volume":"50","author":"S Enterlein","year":"2006","unstructured":"Enterlein, S., Warfield, K. L., Swenson, D. L., Stein, D. A., Smith, J. L., Gamble, C. S., Kroeker, A. D., Iversen, P. L., Bavari, S., & Muhlberger, E. (2006). VP35 knockdown inhibits Ebola virus amplification and protects against lethal infection in mice. Antimicrobial Agents and Chemotherapy, 50, 984\u2013993.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"679_CR140","doi-asserted-by":"publisher","first-page":"3724","DOI":"10.1128\/AAC.00644-06","volume":"50","author":"Q Ge","year":"2006","unstructured":"Ge, Q., Pastey, M., Kobasa, D., Puthavathana, P., Lupfer, C., Bestwick, R. K., Iversen, P. L., Chen, J., & Stein, D. A. (2006). Inhibition of multiple subtypes of influenza A virus in cell cultures with morpholino oligomers. Antimicrobial Agents and Chemotherapy, 50, 3724\u20133733.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"679_CR141","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1111\/j.1600-0854.2007.00572.x","volume":"8","author":"F Duchardt","year":"2007","unstructured":"Duchardt, F., Fotin-Mleczek, M., Schwarz, H., Fischer, R., & Brock, R. (2007). A comprehensive model for the cellular uptake of cationic cell-penetrating peptides. Traffic, 8, 848\u2013866.","journal-title":"Traffic"},{"key":"679_CR142","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/biom9010022","volume":"9","author":"S Silva","year":"2019","unstructured":"Silva, S., Almeida, A. J., & Vale, N. (2019). Combination of cell-penetrating peptides with nanoparticles for therapeutic application: A review. Biomolecules, 9, 22.","journal-title":"Biomolecules"},{"key":"679_CR143","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.bbamem.2010.02.009","volume":"1798","author":"ID Alves","year":"2010","unstructured":"Alves, I. D., Jiao, C. Y., Aubry, S., Aussedat, B., Burlina, F., Chassaing, G., & Sagan, S. (2010). Cell biology meets biophysics to unveil the different mechanisms of penetratin internalization in cells. Biochimica et Biophysica Acta (BBA)-Biomembranes., 1798, 2231\u20132239.","journal-title":"Biochimica et Biophysica Acta (BBA)-Biomembranes."},{"key":"679_CR144","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1016\/j.febslet.2013.04.031","volume":"587","author":"C Bechara","year":"2013","unstructured":"Bechara, C., & Sagan, S. (2013). Cell-penetrating peptides: 20 years later, where do we stand? FEBS Letters, 587, 1693\u20131702.","journal-title":"FEBS Letters"},{"key":"679_CR145","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1021\/bi035682s","volume":"43","author":"S Deshayes","year":"2004","unstructured":"Deshayes, S., Heitz, A., Morris, M. C., Charnet, P., Divita, G., & Heitz, F. (2004). Insight into the mechanism of internalization of the cell-penetrating carrier peptide Pep-1 through conformational analysis. Biochemistry, 43, 1449\u20131457.","journal-title":"Biochemistry"},{"key":"679_CR146","doi-asserted-by":"crossref","unstructured":"Chassaing, G., Sagan, S., Lequin, O., Lamaziere, A., Ayala-Sanmartin, J., & Trugnan, G. (2005). Six inverted lipid models: A pathway for peptide internalization? Half Title, 89","DOI":"10.1201\/9781420006087.ch6"},{"key":"679_CR147","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/icb.2011.20","volume":"89","author":"JP Lim","year":"2011","unstructured":"Lim, J. P., & Gleeson, P. A. (2011). Macropinocytosis: An endocytic pathway for internalising large gulps. Immunology and Cell Biology, 89, 836\u2013843.","journal-title":"Immunology and Cell Biology"},{"key":"679_CR148","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1038\/mt.2013.54","volume":"21","author":"A El-Sayed","year":"2013","unstructured":"El-Sayed, A., & Harashima, H. (2013). Endocytosis of gene delivery vectors: From clathrin-dependent to lipid raft-mediated endocytosis. Molecular Therapy, 21, 1118\u20131130.","journal-title":"Molecular Therapy"},{"key":"679_CR149","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.addr.2007.09.012","volume":"60","author":"S Pujals","year":"2008","unstructured":"Pujals, S., & Giralt, E. (2008). Proline-rich, amphipathic cell-penetrating peptides. Advanced Drug Delivery Reviews, 60, 473\u2013484.","journal-title":"Advanced Drug Delivery Reviews"},{"key":"679_CR150","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1042\/bj20031253","volume":"377","author":"J Rejman","year":"2004","unstructured":"Rejman, J., Oberle, V., Zuhorn, I. S., & Hoekstra, D. (2004). Size-dependent internalization of particles via the pathways of clathrin-and caveolae-mediated endocytosis. Biochemical Journal, 377, 159\u2013169.","journal-title":"Biochemical Journal"},{"key":"679_CR151","doi-asserted-by":"publisher","first-page":"5836","DOI":"10.1074\/jbc.M007540200","volume":"276","author":"S Futaki","year":"2001","unstructured":"Futaki, S., Suzuki, T., Ohashi, W., Yagami, T., Tanaka, S., Ueda, K., & Sugiura, Y. (2001). Arginine-rich peptides: An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. Journal of Biological Chemistry, 276, 5836\u20135840.","journal-title":"Journal of Biological Chemistry"},{"key":"679_CR152","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1016\/j.bpj.2010.08.029","volume":"99","author":"ST Yang","year":"2010","unstructured":"Yang, S. T., Zaitseva, E., Chernomordik, L. V., & Melikov, K. (2010). Cell-penetrating peptide induces leaky fusion of liposomes containing late endosome-specific anionic lipid. Biophysical Journal, 99, 2525\u20132533.","journal-title":"Biophysical Journal"},{"key":"679_CR153","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1208\/s12248-008-9071-2","volume":"11","author":"A El-Sayed","year":"2009","unstructured":"El-Sayed, A., Futaki, S., & Harashima, H. (2009). Delivery of macromolecules using arginine-rich cell-penetrating peptides: Ways to overcome endosomal entrapment. The AAPS Journal, 11, 13\u201322.","journal-title":"The AAPS Journal"},{"key":"679_CR154","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/nm996","volume":"10","author":"JS Wadia","year":"2004","unstructured":"Wadia, J. S., Stan, R. V., & Dowdy, S. F. (2004). Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nature Medicine, 10, 310\u2013315.","journal-title":"Nature Medicine"},{"key":"679_CR155","doi-asserted-by":"publisher","first-page":"13003","DOI":"10.1073\/pnas.97.24.13003","volume":"97","author":"PA Wender","year":"2000","unstructured":"Wender, P. A., Mitchell, D. J., Pattabiraman, K., Pelkey, E. T., Steinman, L., & Rothbard, J. B. (2000). The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: Peptoid molecular transporters. Proceedings of the National Academy of Sciences, 97, 13003\u201313008.","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"679_CR156","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/nature01581","volume":"423","author":"Y Jiang","year":"2003","unstructured":"Jiang, Y., Ruta, V., Chen, J., Lee, A., & MacKinnon, R. (2003). The principle of gating charge movement in a voltage-dependent K+ channel. Nature, 423, 42\u201348.","journal-title":"Nature"},{"key":"679_CR157","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.bbrc.2008.04.039","volume":"371","author":"HL \u00c5mand","year":"2008","unstructured":"\u00c5mand, H. L., Fant, K., Nord\u00e9n, B., & Esbj\u00f6rner, E. K. (2008). Stimulated endocytosis in penetratin uptake: Effect of arginine and lysine. Biochemical and Biophysical Research Communications, 371, 621\u2013625.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"679_CR158","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.bbamem.2014.11.013","volume":"1848","author":"ML Jobin","year":"2015","unstructured":"Jobin, M. L., Blanchet, M., Henry, S., Chaignepain, S., Manigand, C., Castano, S., Lecomte, S., Burlina, F., Sagan, S., & Alves, I. D. (2015). The role of tryptophans on the cellular uptake and membrane interaction of arginine-rich cell penetrating peptides. Biochimica et Biophysica Acta (BBA)-Biomembranes, 1848, 593\u2013602.","journal-title":"Biochimica et Biophysica Acta (BBA)-Biomembranes"},{"key":"679_CR159","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1016\/j.bbamem.2010.02.027","volume":"1798","author":"L Kurzawa","year":"2010","unstructured":"Kurzawa, L., Pellerano, M., & Morris, M. C. (2010). PEP and CADY-mediated delivery of fluorescent peptides and proteins into living cells. Biochimica et Biophysica Acta (BBA)-Biomembranes, 1798, 2274\u20132285.","journal-title":"Biochimica et Biophysica Acta (BBA)-Biomembranes"},{"key":"679_CR160","first-page":"41","volume":"25","author":"K Kamide","year":"2010","unstructured":"Kamide, K., Nakakubo, H., Uno, S., & Fukamizu, A. (2010). Isolation of novel cell-penetrating peptides from a random peptide library using in vitro virus and their modifications. International Journal of Molecular Medicine, 25, 41\u201351.","journal-title":"International Journal of Molecular Medicine"},{"key":"679_CR161","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1002\/psc.1003","volume":"14","author":"ST Henriques","year":"2008","unstructured":"Henriques, S. T., & Castanho, M. A. (2008). Translocation or membrane disintegration? Implication of peptide\u2013membrane interactions in pep-1 activity. Journal of Peptide Science: An Official Publication of the European Peptide Society, 14, 482\u2013487.","journal-title":"Journal of Peptide Science: An Official Publication of the European Peptide Society"},{"key":"679_CR162","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1039\/C6TB02862D","volume":"5","author":"Z Meng","year":"2017","unstructured":"Meng, Z., Luan, L., Kang, Z., Feng, S., Meng, Q., & Liu, K. (2017). Histidine-enriched multifunctional peptide vectors with enhanced cellular uptake and endosomal escape for gene delivery. Journal of Materials Chemistry B, 5, 74\u201384.","journal-title":"Journal of Materials Chemistry B"},{"key":"679_CR163","doi-asserted-by":"publisher","first-page":"121308","DOI":"10.1016\/j.ijpharm.2021.121308","volume":"611","author":"J V\u00e1\u0148ov\u00e1","year":"2022","unstructured":"V\u00e1\u0148ov\u00e1, J., \u010c\u00edha\u0159ov\u00e1, B., Hejtm\u00e1nkov\u00e1, A., Epperla, C. P., \u0160kv\u00e1ra, P., Forstov\u00e1, J., Kalbacova, M. H., & Spanielova, H. (2022). VirPorters: Insights into the action of cationic and histidine-rich cell-penetrating peptides. International Journal of Pharmaceutics, 611, 121308.","journal-title":"International Journal of Pharmaceutics"},{"key":"679_CR164","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3390\/biom2020187","volume":"2","author":"WL Munyendo","year":"2012","unstructured":"Munyendo, W. L., Lv, H., Benza-Ingoula, H., Baraza, L. D., & Zhou, J. (2012). Cell penetrating peptides in the delivery of biopharmaceuticals. Biomolecules, 2, 187\u2013202.","journal-title":"Biomolecules"},{"key":"679_CR165","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.3390\/ijms21072536","volume":"21","author":"I Gessner","year":"2020","unstructured":"Gessner, I., & Neundorf, I. (2020). Nanoparticles modified with cell-penetrating peptides: Conjugation mechanisms, physicochemical properties, and application in cancer diagnosis and therapy. International Journal of Molecular Sciences, 21, 2536.","journal-title":"International Journal of Molecular Sciences"},{"key":"679_CR166","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.bbcan.2009.09.004","volume":"1805","author":"NA Brooks","year":"2010","unstructured":"Brooks, N. A., Pouniotis, D. S., Tang, C. K., Apostolopoulos, V., & Pietersz, G. A. (2010). Cell-penetrating peptides: application in vaccine delivery. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer, 1805, 25\u201334.","journal-title":"Biochimica et Biophysica Acta (BBA)-Reviews on Cancer"},{"key":"679_CR167","doi-asserted-by":"publisher","first-page":"106094","DOI":"10.1016\/j.ejps.2021.106094","volume":"169","author":"I Sadeghian","year":"2021","unstructured":"Sadeghian, I., Heidari, R., Sadeghian, S., Raee, M. J., & Negahdaripour, M. (2021). Potential of cell-penetrating peptides (CPPs) in delivery of antiviral therapeutics and vaccines. European Journal of Pharmaceutical Sciences, 169, 106094.","journal-title":"European Journal of Pharmaceutical Sciences"},{"key":"679_CR168","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035187","volume":"7","author":"P Kapoor","year":"2012","unstructured":"Kapoor, P., Singh, H., Gautam, A., Chaudhary, K., Kumar, R., & Raghava, G. P. (2012). TumorHoPe: A database of tumor homing peptides. PLoS ONE, 7, e35187.","journal-title":"PLoS ONE"},{"key":"679_CR169","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.3390\/cancers11101571","volume":"11","author":"F Meng","year":"2019","unstructured":"Meng, F., Sun, Y., Lee, R. J., Wang, G., Zheng, X., Zhang, H., Fu, Y., Yan, G., Wang, Y., Deng, W., Parks, E., Kim, B. Y. S., Yang, Z., Jiang, W., & Teng, L. (2019). Folate receptor-targeted albumin nanoparticles based on microfluidic technology to deliver cabazitaxel. Cancers, 11, 1571.","journal-title":"Cancers"},{"key":"679_CR170","doi-asserted-by":"publisher","first-page":"e0136649","DOI":"10.1371\/journal.pone.0136649","volume":"10","author":"X Yang","year":"2015","unstructured":"Yang, X., Yang, S., Chai, H., Yang, Z., Lee, R. J., Liao, W., & Teng, L. (2015). A novel isoquinoline derivative anticancer agent and its targeted delivery to tumor cells using transferrin-conjugated liposomes. PLoS ONE, 10, e0136649.","journal-title":"PLoS ONE"},{"key":"679_CR171","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jconrel.2014.12.002","volume":"205","author":"J Ye","year":"2015","unstructured":"Ye, J., Shin, M. C., Liang, Q., He, H., & Yang, V. C. (2015). 15 years of ATTEMPTS: A macromolecular drug delivery system based on the CPP-mediated intracellular drug delivery and antibody targeting. Journal of Controlled Release, 205, 58\u201369.","journal-title":"Journal of Controlled Release"},{"key":"679_CR172","doi-asserted-by":"publisher","first-page":"697","DOI":"10.3389\/fphar.2020.00697","volume":"11","author":"J Xie","year":"2020","unstructured":"Xie, J., Bi, Y., Zhang, H., Dong, S., Teng, L., Lee, R. J., & Yang, Z. (2020). Cell-penetrating peptides in diagnosis and treatment of human diseases: From preclinical research to clinical application. Frontiers in Pharmacology, 11, 697.","journal-title":"Frontiers in Pharmacology"},{"key":"679_CR173","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.tips.2010.07.006","volume":"31","author":"P J\u00e4rver","year":"2010","unstructured":"J\u00e4rver, P., M\u00e4ger, I., & Langel, \u00dc. (2010). In vivo biodistribution and efficacy of peptide mediated delivery. Trends in Pharmacological Sciences, 31, 528\u2013535.","journal-title":"Trends in Pharmacological Sciences"},{"key":"679_CR174","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ab.2005.07.033","volume":"345","author":"K Saar","year":"2005","unstructured":"Saar, K., Lindgren, M., Hansen, M., Eiriksdottir, E., Jiang, Y., Rosenthal-Aizman, K., Sassian, M., & Langel, U. (2005). Cell-penetrating peptides: A comparative membrane toxicity study. Analytical Biochemistry, 345, 55\u201365.","journal-title":"Analytical Biochemistry"},{"key":"679_CR175","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.3390\/ph5111177","volume":"5","author":"A Erazo-Oliveras","year":"2012","unstructured":"Erazo-Oliveras, A., Muthukrishnan, N., Baker, R., Wang, T. Y., & Pellois, J. P. (2012). Improving the endosomal escape of cell-penetrating peptides and their cargos: Strategies and challenges. Pharmaceuticals, 5, 1177\u20131209.","journal-title":"Pharmaceuticals"},{"key":"679_CR176","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.2174\/138161208785777432","volume":"14","author":"V Kersemans","year":"2008","unstructured":"Kersemans, V., Kersemans, K., & Cornelissen, B. (2008). Cell penetrating peptides for in vivo molecular imaging applications. Current Pharmaceutical Design, 14, 2415\u20132427.","journal-title":"Current Pharmaceutical Design"}],"container-title":["Molecular Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-023-00679-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12033-023-00679-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-023-00679-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T15:12:43Z","timestamp":1744211563000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12033-023-00679-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,31]]},"references-count":176,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["679"],"URL":"https:\/\/doi.org\/10.1007\/s12033-023-00679-1","relation":{},"ISSN":["1073-6085","1559-0305"],"issn-type":[{"value":"1073-6085","type":"print"},{"value":"1559-0305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,31]]},"assertion":[{"value":"9 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by author.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}